Biopsafe ApS: Financial statements 2024
CVR: 33575505
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 11,278,000 and a net result of DKK 4,087,000 compared with DKK 79,000 the year before. That is an increase of 55.9% compared with the year before. Equity in the 2024 report amounted to DKK 9,087,000. The solvency ratio was 34.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 11,278,000
- Profit/Loss
- DKK 4,087,000
- Equity
- DKK 9,087,000
- Total Assets
- DKK 26,404,000
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 11.3 mio. | 4.1 mio. | 9.1 mio. | 3 |
| 2023 | - | 7.2 mio. | 79 t. | 5.1 mio. | 4 |
| 2022 | - | 6.1 mio. | 1.4 mio. | 5.7 mio. | 2 |
| 2021 | - | 7.5 mio. | 250 t. | 4.3 mio. | 3 |
| 2020 | - | 5.2 mio. | 219 t. | 4 mio. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Biopsafe ApS has published its annual report for 2023. Gross profit came to DKK 7,235,000, and the net result was DKK 79,000.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.